Physician profile
Chadwick Davis
NPI 1750348868
$2,593.78
in general payments reported to CMS, 2019-2025
9 companies · $489 in 2025
The $489 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $97.40 · 2021: $56.36 · 2022: $50.53 · 2023: $351 · 2024: $864 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Gift: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.28 |
| Gift | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $857.02 | 2023-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $619.98 | 2019-2020 | |
| Alcon Vision LLC | $516.34 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Visionary Optics LLC | $400.00 | 2024 | |
| Oyster Point Pharma, INC. | $87.09 | 2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $58.88 | 2020-2022 | |
| Shire North American Group INC | $19.73 | 2019 | |
| Bausch & Lomb Americas INC. | $19.10 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadwick Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.